These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32509785)

  • 1. Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.
    Smits LM; Schwamborn JC
    Front Cell Dev Biol; 2020; 8():359. PubMed ID: 32509785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.
    Monzel AS; Smits LM; Hemmer K; Hachi S; Moreno EL; van Wuellen T; Jarazo J; Walter J; Brüggemann I; Boussaad I; Berger E; Fleming RMT; Bolognin S; Schwamborn JC
    Stem Cell Reports; 2017 May; 8(5):1144-1154. PubMed ID: 28416282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Parkinson's disease in midbrain-like organoids.
    Smits LM; Reinhardt L; Reinhardt P; Glatza M; Monzel AS; Stanslowsky N; Rosato-Siri MD; Zanon A; Antony PM; Bellmann J; Nicklas SM; Hemmer K; Qing X; Berger E; Kalmbach N; Ehrlich M; Bolognin S; Hicks AA; Wegner F; Sterneckert JL; Schwamborn JC
    NPJ Parkinsons Dis; 2019; 5():5. PubMed ID: 30963107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease.
    Galet B; Cheval H; Ravassard P
    Front Neurol; 2020; 11():1005. PubMed ID: 33013664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
    Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Evaluation of Parkinson's Disease Patient-Derived Midbrain Organoids Using Mesoporous Au Nanodot-Patterned 3D Concave Electrode.
    An J; Shin M; Beak G; Yoon J; Kim S; Cho HY; Choi JW
    ACS Sens; 2024 Jul; ():. PubMed ID: 38954790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.
    Nickels SL; Modamio J; Mendes-Pinheiro B; Monzel AS; Betsou F; Schwamborn JC
    Stem Cell Res; 2020 Jul; 46():101870. PubMed ID: 32534166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
    Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
    Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling.
    Kwak TH; Kang JH; Hali S; Kim J; Kim KP; Park C; Lee JH; Ryu HK; Na JE; Jo J; Je HS; Ng HH; Kwon J; Kim NH; Hong KH; Sun W; Chung CH; Rhyu IJ; Han DW
    Stem Cells; 2020 Jun; 38(6):727-740. PubMed ID: 32083763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons.
    Jo J; Xiao Y; Sun AX; Cukuroglu E; Tran HD; Göke J; Tan ZY; Saw TY; Tan CP; Lokman H; Lee Y; Kim D; Ko HS; Kim SO; Park JH; Cho NJ; Hyde TM; Kleinman JE; Shin JH; Weinberger DR; Tan EK; Je HS; Ng HH
    Cell Stem Cell; 2016 Aug; 19(2):248-257. PubMed ID: 27476966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 14. A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson's disease mouse model.
    Fu CL; Dong BC; Jiang X; Li D; Yao J
    Heliyon; 2024 Jan; 10(2):e24234. PubMed ID: 38293351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
    Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids.
    Smits LM; Magni S; Kinugawa K; Grzyb K; Luginbühl J; Sabate-Soler S; Bolognin S; Shin JW; Mori E; Skupin A; Schwamborn JC
    Cell Tissue Res; 2020 Dec; 382(3):463-476. PubMed ID: 32737576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfabricated disk technology: Rapid scale up in midbrain organoid generation.
    Mohamed NV; Lépine P; Lacalle-Aurioles M; Sirois J; Mathur M; Reintsch W; Beitel LK; Fon EA; Durcan TM
    Methods; 2022 Jul; 203():465-477. PubMed ID: 34314827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screening.
    Zanetti C; Spitz S; Berger E; Bolognin S; Smits LM; Crepaz P; Rothbauer M; Rosser JM; Marchetti-Deschmann M; Schwamborn JC; Ertl P
    Analyst; 2021 Apr; 146(7):2358-2367. PubMed ID: 33625407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
    Renner H; Schöler HR; Bruder JM
    Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions.
    Ozgun A; Lomboni DJ; Aylsworth A; Macdonald A; Staines WA; Martina M; Schlossmacher MG; Tauskela JS; Woulfe J; Variola F
    Mater Today Bio; 2024 Apr; 25():100992. PubMed ID: 38371467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.